Camson Bio Technologies (BOM:538858) EBITDA Margin %: -266.09% (As of Mar. 2019)


BOM:538858 Camson Bio Technologies Ltd BOM:538858
4 GF Score
Price ₹3.31
View Full Analysis

What is Camson Bio Technologies EBITDA Margin %?

Camson Bio Technologies BOM:538858 4 EBITDA Margin % is -266.09% as of Mar. 2019. GuruFocus rates BOM:538858 with a GF Score™ of 4/100.

EBITDA Margin % is calculated as EBITDA divided by its Revenue. Camson Bio Technologies's EBITDA for the six months ended in Mar. 2019 was ₹-132.41 Mil. Camson Bio Technologies's Revenue for the six months ended in Mar. 2019 was ₹49.76 Mil. Therefore, Camson Bio Technologies's EBITDA margin for the quarter that ended in Mar. 2019 was -266.09%.

Camson Bio Technologies  (BOM:538858) EBITDA Margin % Explanation

EBITDA Margin % is the ratio of EBITDA divided by net sales or Revenue. It is an performance metric measuring company's operating profitability. EBITDA Margin takes depreciation and amortization, interest expense and tax into account, which makes it easy to compare the relative profitability of companies of different sizes in the same industry.

Camson Bio Technologies EBITDA Margin % Related Terms

Camson Bio Technologies EBITDA Margin % Historical Data

* Premium members only.

The historical data trend for Camson Bio Technologies's EBITDA Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Camson Bio Technologies EBITDA Margin % Chart

Camson Bio Technologies Annual Data
Trend Mar10 Mar11 Mar12 Mar13 Mar14 Mar15 Mar16 Mar17 Mar18 Mar19
EBITDA Margin %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 9.67 -22.91 -74.14 5.62 -266.09

Camson Bio Technologies Semi-Annual Data
Mar07 Mar08 Mar09 Mar10 Mar11 Mar12 Mar13 Mar14 Mar15 Mar16 Mar17 Mar18 Mar19
EBITDA Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 9.67 -22.91 -74.14 5.62 -266.09

BOM:538858 vs CTVA, FMC, SMG: EBITDA Margin % Comparison

For the Agricultural Inputs subindustry, Camson Bio Technologies's EBITDA Margin %, along with its competitors' market caps and EBITDA Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Camson Bio Technologies EBITDA Margin % vs Agriculture Industry

For the Agriculture industry and Basic Materials sector, Camson Bio Technologies's EBITDA Margin % distribution charts can be found below:

* The bar in red indicates where Camson Bio Technologies's EBITDA Margin % falls into.


BOM:538858
4GF Score
Camson Bio Technologies Ltd BOM:538858
EBITDA Margin % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Camson Bio Technologies EBITDA Margin % Calculation

EBITDA margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent.

Camson Bio Technologies's EBITDA Margin % for the fiscal year that ended in Mar. 2019 is calculated as

EBITDA Margin %=EBITDA (A: Mar. 2019 )/Revenue (A: Mar. 2019 )
=-132.414/49.762
=-266.09 %

Camson Bio Technologies's EBITDA Margin % for the quarter that ended in Mar. 2019 is calculated as

EBITDA Margin %=EBITDA (Q: Mar. 2019 )/Revenue (Q: Mar. 2019 )
=-132.414/49.762
=-266.09 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about EBITDA Margin % →
What does a EBITDA Margin % of -266.09% mean?
Camson Bio Technologies (BOM:538858) has a EBITDA Margin % of -266.09% as of Mar. 2019. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Camson Bio Technologies and its competitors.
Is Camson Bio Technologies' EBITDA Margin % too high?
Camson Bio Technologies' current EBITDA Margin % is -266.09%. Overall, Camson Bio Technologies has a GF Score™ of 4/100, reflecting its overall financial health beyond just this single metric.
How does Camson Bio Technologies' EBITDA Margin % compare to CTVA and FMC?
Camson Bio Technologies' EBITDA Margin % of -266.09% can be compared against companies in the Agriculture industry. The industry median EBITDA Margin % is 9.67. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBITDA Margin % for an Agriculture company?
The median EBITDA Margin % among Agriculture companies is 9.67, based on 248 companies in the industry. Companies in the top quartile (top 25%) have a EBITDA Margin % significantly above this median, while those in the bottom quartile fall well below. However, EBITDA Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBITDA Margin % mean?
A high EBITDA Margin % can signal that a stock is expensive relative to its fundamentals. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Camson Bio Technologies and its competitors. For the Agriculture industry, the median EBITDA Margin % is 9.67 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Camson Bio Technologies's current EBITDA Margin % is -266.09%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Camson Bio Technologies stock overvalued right now?
Camson Bio Technologies (BOM:538858) has a current EBITDA Margin % of -266.09%. The current EBITDA Margin % is -266.09%. Camson Bio Technologies' overall GF Score™ is 4/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBITDA Margin % calculated?
EBITDA Margin % is calculated from a company's financial statements. For Camson Bio Technologies (BOM:538858), the current EBITDA Margin % is -266.09% as of Mar. 2019. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Camson Bio Technologies Business Description

Address Golden Enclave, Old Airport Road, C-7, 7th Floor, Corporate Block, Bangalore, KA, IND, 560017
Camson Bio Technologies Ltd is an agricultural biotechnology company. The firm is involved in the business of research, manufacturing and marketing of crop nutrition, bio-pesticide, natural fertilizers, bio fertilizers, bio-stimulants and hybrid seed varieties. The entire turnover of the company is from domestic business.
4GF Score

Get the complete analysis for BOM:538858

EBITDA Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹3.31
Price